Cell Reports (Jun 2022)

Absence of microglia promotes diverse pathologies and early lethality in Alzheimer’s disease mice

  • Sepideh Kiani Shabestari,
  • Samuel Morabito,
  • Emma Pascal Danhash,
  • Amanda McQuade,
  • Jessica Ramirez Sanchez,
  • Emily Miyoshi,
  • Jean Paul Chadarevian,
  • Christel Claes,
  • Morgan Alexandra Coburn,
  • Jonathan Hasselmann,
  • Jorge Hidalgo,
  • Kayla Nhi Tran,
  • Alessandra C. Martini,
  • Winston Chang Rothermich,
  • Jesse Pascual,
  • Elizabeth Head,
  • David A. Hume,
  • Clare Pridans,
  • Hayk Davtyan,
  • Vivek Swarup,
  • Mathew Blurton-Jones

Journal volume & issue
Vol. 39, no. 11
p. 110961

Abstract

Read online

Summary: Microglia are strongly implicated in the development and progression of Alzheimer’s disease (AD), yet their impact on pathology and lifespan remains unclear. Here we utilize a CSF1R hypomorphic mouse to generate a model of AD that genetically lacks microglia. The resulting microglial-deficient mice exhibit a profound shift from parenchymal amyloid plaques to cerebral amyloid angiopathy (CAA), which is accompanied by numerous transcriptional changes, greatly increased brain calcification and hemorrhages, and premature lethality. Remarkably, a single injection of wild-type microglia into adult mice repopulates the microglial niche and prevents each of these pathological changes. Taken together, these results indicate the protective functions of microglia in reducing CAA, blood-brain barrier dysfunction, and brain calcification. To further understand the clinical implications of these findings, human AD tissue and iPSC-microglia were examined, providing evidence that microglia phagocytose calcium crystals, and this process is impaired by loss of the AD risk gene, TREM2.

Keywords